On February 11, 2014 10:12 (IST)
Taro said on Monday that its net sales for October-December grew 15 per cent to $213.6 million and earnings per share was at $2.59 per share.
On February 10, 2014 13:06 (IST)
Shares of Indian pharmaceutical companies perceived as defensive gain on risk aversion after overseas investors sold Rs 267 crore worth of Indian shares on Friday, extending their selling streak to a seventh day, provisional exchange data shows, deal...
On December 02, 2013 13:27 (IST)
Drug makers such as Ranbaxy, up 6 per cent, and Sun Pharma, up 3.6 per cent, also saw buying interest. Shares in Larsen and Toubro gained 2.3 per cent after the company said on Friday it was evaluating options "for monetisation" of assets belonging t...
On November 26, 2013 10:43 (IST)
If the offer is fully subscribed, the number of Taro shares to be purchased in the offer represents approximately 4.6 to 5.3 per cent of the unit's total outstanding shares.
On December 17, 2013 15:26 (IST)
Taro's quarterly earnings per share came at $2.15 while sales rose 27.5 per cent to $205.3 million.
On October 25, 2013 17:35 (IST)
The BSE Sensex fell on Friday, failing to extend their third weekly gains, as some blue chip shares such as Sun Pharmaceutical were hit by profit-taking after marking their highest level since November 2010 earlier in the week.
On July 29, 2013 11:13 (IST)
Sun announced it would grant one bonus share per existing share as part of its earnings January-March earnings results, thus completing a stock split that has doubled the number of outstanding shares.
On June 03, 2013 11:05 (IST)
Shares in Sun Pharmaceutical Industries Ltd fell as much as 2.3 per cent on Monday on media reports that the company is in talks to buy Sweden's Meda AB for between $5-6 billion.
On June 03, 2013 15:21 (IST)
The BSE Sensex fell around 60 points and the Nifty traded down 25 points. Shares in Maruti Suzuki fell 3 per cent after the automaker's sales declined 14.4 per cent in May compared with a year earlier.
On May 29, 2013 09:45 (IST)
Global brokerage CLSA continues to be positive on Sun Pharma after India's No. 3 drugmaker by sales reported a 23.4 per cent rise in net profit during the fourth-quarter ended March to Rs 1,012 crore.